ginsenoside rh2 has been researched along with Corneal Neovascularization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, C; Ge, HM; Jiang, Q; Li, KR; Li, XM; Yao, J; Yao, MD; Yu, Q; Zhang, XP | 1 |
1 other study(ies) available for ginsenoside rh2 and Corneal Neovascularization
Article | Year |
---|---|
Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents; Cornea; Corneal Neovascularization; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; Ice; Male; MAP Kinase Signaling System; Mice, Inbred ICR; Phosphoproteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2018 |